Is there any evidence implying the use of a different criterion for protective anti-HBs titer after HBV vaccination in immunosuppressed patients?
(Turk J Gastroenterol 2020; 31: 346-347) DOI: 10.5152/tjg.2020.19040
(Turk J Gastroenterol 2020; 31: 346-347) DOI: 10.5152/tjg.2020.19040